Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BrightSpring Health Services (BTSG) EBIT (2023 - 2025)

BrightSpring Health Services' EBIT history spans 3 years, with the latest figure at $108.1 million for Q4 2025.

  • For Q4 2025, EBIT rose 94.66% year-over-year to $108.1 million; the TTM value through Dec 2025 reached $295.3 million, up 173.5%, while the annual FY2025 figure was $295.3 million, 173.5% up from the prior year.
  • EBIT reached $108.1 million in Q4 2025 per BTSG's latest filing, up from $87.8 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $108.1 million in Q4 2025 to a low of -$123.8 million in Q4 2023.
  • Average EBIT over 3 years is $29.9 million, with a median of $49.6 million recorded in 2025.
  • Peak YoY movement for EBIT: tumbled 129.74% in 2024, then soared 430.87% in 2025.
  • A 3-year view of EBIT shows it stood at -$123.8 million in 2023, then soared by 144.86% to $55.5 million in 2024, then soared by 94.66% to $108.1 million in 2025.
  • Per Business Quant, the three most recent readings for BTSG's EBIT are $108.1 million (Q4 2025), $87.8 million (Q3 2025), and $48.6 million (Q2 2025).